- Home
- MLAC vs CADL Comparison
MLAC vs CADL Comparison
Compare MLAC & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAC
- CADL
- Stock Information
- Founded
- MLAC 2024
- CADL 1999
- Country
- MLAC United States
- CADL United States
- Employees
- MLAC N/A
- CADL N/A
- Industry
- MLAC
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- MLAC
- CADL Health Care
- Exchange
- MLAC NYSE
- CADL Nasdaq
- Market Cap
- MLAC 314.4M
- CADL 234.8M
- IPO Year
- MLAC 2024
- CADL 2021
- Fundamental
- Price
- MLAC $10.18
- CADL $4.76
- Analyst Decision
- MLAC
- CADL Strong Buy
- Analyst Count
- MLAC 0
- CADL 4
- Target Price
- MLAC N/A
- CADL $21.00
- AVG Volume (30 Days)
- MLAC 94.6K
- CADL 864.6K
- Earning Date
- MLAC 01-01-0001
- CADL 05-13-2025
- Dividend Yield
- MLAC N/A
- CADL N/A
- EPS Growth
- MLAC N/A
- CADL N/A
- EPS
- MLAC N/A
- CADL N/A
- Revenue
- MLAC N/A
- CADL N/A
- Revenue This Year
- MLAC N/A
- CADL N/A
- Revenue Next Year
- MLAC N/A
- CADL N/A
- P/E Ratio
- MLAC $415.34
- CADL N/A
- Revenue Growth
- MLAC N/A
- CADL N/A
- 52 Week Low
- MLAC $9.94
- CADL $3.79
- 52 Week High
- MLAC $10.17
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- MLAC N/A
- CADL 41.42
- Support Level
- MLAC N/A
- CADL $4.80
- Resistance Level
- MLAC N/A
- CADL $5.34
- Average True Range (ATR)
- MLAC 0.00
- CADL 0.33
- MACD
- MLAC 0.00
- CADL 0.10
- Stochastic Oscillator
- MLAC 0.00
- CADL 42.09
About MLAC MOUNTAIN LAKE ACQUISITION CORP
Mountain Lake Acquisition Corp is a blank check company.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.